TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: MPO (Myeloperoxidase) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed gastric emptying of a liquid meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-reported learning values
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-reported stress level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recurrence rate of CRPS
Endpoint domain: Mortality/survival
Primary endpoint: postintervention primary patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Bond strength to resin cement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean TNSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to Vi antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response to S. Typhi and O-9,12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response to H-d antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HIV-RNA suppression < 50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean CD4+ cell counts increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: AI (Asynchrony Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure support (PS) variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain-related outcomes improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean total cost of treatment package
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in corneal curvature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability of astigmatism change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial triglycerides response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC(0‐t) of losartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of losartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0‐t) of E‐3174
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of E‐3174
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative renal survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Slope of reciprocal serum creatinine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Standard drinks consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of the combined endpoint
Endpoint domain: Mortality/survival
Primary endpoint: Survival free of major cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Progression rate of mucositis from grade 2 to 3
Endpoint domain: Adverse events/effects
Primary endpoint: First new WHO stage 4 events or death
Endpoint domain: Mortality/survival
Primary endpoint: Cost-effectiveness of tension-free vaginal tape vs laparoscopic mesh colposuspension
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Crown integrity after 7 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of GIA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hemodynamic alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional stress reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preparedness for symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in IRLS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain responses to bladder filling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of variceal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CI Symptom Survey score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: hours of crying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall score for side effects
Endpoint domain: Adverse events/effects
Primary endpoint: excellent and good rate according to the Maryland foot score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incision complications
Endpoint domain: Adverse events/effects
Primary endpoint: 12-Month remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First seizure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC and Cmax ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBFV of the MCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue coating scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Organoleptic score of oral malodour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PC (Protein Carbonyls)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: MDA (Malondialdehyde)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Seven valid days of accelerometer wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of atrial tachyarrhythmia (Ata)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial glucose responses (incremental area under curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Delta postprandial peak glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of life in cancer survivorship
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Optimum Cardiac Output (OptCO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Arterial Pressure (OptMAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reactive hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of no-reflow/slow-flow phenomenon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of persistent ST-segment elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of non-Q-wave MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Signal intensity in muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signal intensity in carotid artery wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cluster robustness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mandibular overdentures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total OHIP score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24 h urinary free cortisol values below the reference range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: onset of the first asthma exacerbation or increased asthma symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rates of stroke or systemic embolic events
Endpoint domain: Mortality/survival
Primary endpoint: Rates of major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: CT value of tumor blood supply arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNR of tumor blood supply arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOM of tumor blood supply arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days off work
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cannulation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Phosphocreatine (PCr) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Inorganic phosphate (Pi) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intracellular pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maternal serum IGFBP-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cord serum IGFBP-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Circulating IGFBP-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: collisions
Endpoint domain: Adverse events/effects
Primary endpoint: off-road accidents
Endpoint domain: Adverse events/effects
Primary endpoint: driving impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to sensory block at T10 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resolution of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best-corrected visual acuity worse than 20/40
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal cuff dehiscence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Length of labor stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Apgar score > 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in procollagen‐1‐carboxy terminal peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shortening of QTc
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in risk of sudden cardiac death
Endpoint domain: Mortality/survival
Primary endpoint: Treatment change recommendation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: General well-being improvements
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean %USTEPiP3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative net blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mRSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with at least 50% pain intensity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cortical perfusion levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: excess bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: lean soft tissue mass loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ratio of trunk to leg fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall six months costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean total patient cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Loss of productive time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gastric tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of women at action stage
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Comfort levels and attitudes toward pregnant women with substance-use disorders
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: state anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cortisol responses to stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: duration of presence of blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesics requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-esteem changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: drive for thinness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discontinuation of S-1 adjuvant treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Crying duration after injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression in c‐IMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1-year all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: prolonged ventilatory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: need for new mechanical support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reduction of sexually inappropriate behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CUN-BAE (percentage of body fat)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants' understanding of biobank consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participant confidence in understanding biobank consent materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time taken to complete consent process
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in post-test S. mutans counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to first regimen failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip strength loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pillar pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levine scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of positive Epstein-Barr virus viremias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: time-trade-off utilities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tourniquet related anesthesia technique discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean weight before discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time of meconium turning yellow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: time of first defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in UACR category
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of sinus rhythm (SR)
Endpoint domain: Physiological/clinical
Primary endpoint: Quality of life (SF36 score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: seated IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Peak block height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete block regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 Bodily Pain subscale improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in bone marrow lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean Dermatology Life Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean Psoriasis Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reduced folate level in CRC tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain or discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive in vivo penetration test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: C-peptide negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: mean reductions in total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean reductions in LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: predicted 8‐year coronary risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Exclusive breastfeeding (EBF) duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bayley‐III composite scores in cognitive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bayley‐III composite scores in motor functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: muscle activity (∑∫EMG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: center‐of‐pressure displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart failure events or death
Endpoint domain: Mortality/survival
Primary endpoint: Receipt of at least one vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of all needed adolescent vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthcare utilisation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gastric pH >4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to reach gastric pH >4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of gastric pH >4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Recurrent prolapse
Endpoint domain: Adverse events/effects
Primary endpoint: Persistence of itching
Endpoint domain: Adverse events/effects
Primary endpoint: Tenesmus
Endpoint domain: Adverse events/effects
Primary endpoint: Creatinine elimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: axial compression stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean horizontal bone width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of the gel
Endpoint domain: Adverse events/effects
Primary endpoint: Dispensing of targeted medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: WOMAC OA Indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of occipital pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: whole grain intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: self-efficacy for healthy eating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative neurological events
Endpoint domain: Adverse events/effects
Primary endpoint: percent inhibition of clopidogrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: steering variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of deflation failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Glucose incremental area under the curve (iAUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VAS score post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Good quality cytology samples frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma LDL-cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in plasma total cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes